Guaifenesin
Pricing Report NDC 63868-390-14

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

The latest wholesale acquisition cost for Guaifenesin Extended Release (NDC 63868-390-14) is $0.46338 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Aug 17, 2022.

As a provided by Chain Drug Marketing Association Inc, this medication is distributed in a 1 BLISTER PACK in 1 CARTON / 14 TABLET, EXTENDED RELEASE in 1 BLISTER PACK configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.46338
Per EA

Effective Date
Aug 17, 2022
Billable Units
1 EA
Estimated Package Price
$0.46
Data Status
As of Aug 17, 2022
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 BLISTER PACK in 1 CARTON / 14 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Sep 2019, the NADAC wholesale price for (NDC ) has moved within a range of $0.44980 to $0.47343 per EA. Over this 2 years and 10 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.4498 - $0.4734
Market Volatility
5.25% Variance
Latest Trend
0.57%
Date Unit Price Unit Source Method Rate
Aug 17, 2022 $0.46338 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 20, 2022 $0.46602 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 22, 2022 $0.46855 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 18, 2022 $0.46382 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 20, 2022 $0.46247 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 23, 2022 $0.46517 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 23, 2022 $0.45488 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 19, 2022 $0.45112 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 22, 2021 $0.46003 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 17, 2021 $0.45095 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 20, 2021 $0.45927 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 22, 2021 $0.45982 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 18, 2021 $0.45044 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 21, 2021 $0.44980 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 23, 2021 $0.45989 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 19, 2021 $0.45642 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 21, 2021 $0.46364 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 17, 2021 $0.45883 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 17, 2021 $0.45793 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 20, 2021 $0.45964 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 23, 2020 $0.46277 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 18, 2020 $0.46230 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 21, 2020 $0.46231 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 23, 2020 $0.46382 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 19, 2020 $0.45222 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 22, 2020 $0.46034 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 17, 2020 $0.45955 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 20, 2020 $0.46849 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 22, 2020 $0.46519 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 18, 2020 $0.45264 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 19, 2020 $0.47176 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 22, 2020 $0.46387 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 18, 2019 $0.47343 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 23, 2019 $0.46465 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 23, 2019 $0.46465 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Sep 18, 2019 $0.46415 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026